CIM-PC
CIM-PC
US16934Q5053
Chimera Investment Corporation
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 50/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
5/7 Elevated
5 / 7 SRI Price Fluctuation & Beta

Above-average volatility. Suitable for experienced investors with high risk tolerance (5+ years horizon). Moves approx. 1.8x as much as the broader market.

Beta (Market Relation)
1.81x
Above average
Volatility (5Y p.a.)
18.1% p.a.
5-Year Horizon
Max Drawdown (5Y)
-37.1%
5-Year Horizon
Sharpe Ratio
-0.34
Return / Risk
Elevated Risk / Growth: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -8%
3 Years 12.5% -18.7% 0.23 +5.4%
5 Years 18.1% -37.1% -0.34 -3.8%
10 Years 43.1% -71.3% -0.1 —

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 557%.
High market risk: Beta of 1.81 indicates above-average volatility compared to the broader market.
Strong cyclicality: The business model is sensitive to economic downturns.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (18.1% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -71.3% in the extended horizon.

Corporate Governance & ISS Scores

Shareholder rights, board structure and audit safety (Scale 1 = Low Risk, 10 = High Risk)
Overall Governance Risk
-
Audit Risk
-
Board Risk
-
Short Ratio
0.92
ende